Related Experiment Video
Updated: Jul 11, 2026
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Colchicine, a microtubule depolymerizing agent, inhibits myocardial apoptosis in rats
Kenya Saji1, Yoshihiro Fukumoto, Jun Suzuki
1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
The Tohoku Journal of Experimental Medicine
|October 6, 2007
Summary
Microtubule depolymerization may treat heart failure. Colchicine inhibited apoptosis in cultured heart cells and in rats, suggesting a new therapeutic strategy for this common cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Cell Biology
- Pharmacology
Background:
- Heart failure is a leading cause of death, involving increased microtubule polymerization and cardiomyocyte apoptosis.
- The relationship between microtubule dynamics and heart cell death in heart failure is not fully understood.
Purpose of the Study:
- To investigate the link between microtubule polymerization and cardiomyocyte apoptosis in heart failure.
- To evaluate the therapeutic potential of microtubule-depolymerizing agents in heart failure models.
Main Methods:
- Used cultured rat cardiomyocytes and angiotensin II-infused rats (in vitro and in vivo models).
- Assessed microtubule density using confocal microscopy.
- Measured apoptosis via Caspase-3 activity and TUNEL assays.
- Analyzed protein levels (Bax/Bcl-2 ratio) using immunoblotting.
Main Results:
- Paclitaxel increased microtubule density; colchicine decreased it, independent of angiotensin II.
- Angiotensin II increased the Bax/Bcl-2 ratio, indicating apoptosis.
- Colchicine inhibited angiotensin II-induced apoptosis in both cell cultures and in vivo.
- Paclitaxel and angiotensin II enhanced apoptosis; colchicine significantly suppressed it.
Conclusions:
- Microtubule depolymerization, using agents like colchicine, can inhibit cardiomyocyte apoptosis.
- Microtubule-depolymerizing agents represent a potential therapeutic strategy for heart failure.
Related Concept Videos
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...